Detection of Toxigenic Clostridium difficile in Stool Samples by Real-Time Polymerase Chain Reaction for the Diagnosis of C. difficile-Associated Diarrhea
Open Access
- 1 November 2007
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 45 (9) , 1152-1160
- https://doi.org/10.1086/522185
Abstract
Background. Clostridium difficile-associated diarrhea (CDAD) is the major cause of health care-associated infectious diarrhea. Current laboratory testing lacks a single assay that is sensitive, specific, and rapid. The purpose of this work was to design and validate a sensitive and specific real-time polymerase chain reaction (PCR) diagnostic test for CDAD. Methods. This observational validation study of a new real-time PCR assay occurred from July 2004 through April 2006 and involved the testing of 1368 stool samples. As the final validation portion of the investigation, 350 inpatients were prospectively interviewed for clinical findings for 365 episodes of diarrheal illness. Test results and clinical criteria were used to assess the performance of 4 assays. Results. Using clinical criteria requiring at least 3 loose stools in 1 day as part of the reference standard for a positive test result supporting CDAD, the sensitivity, specificity, and positive and negative predictive values were 73.3%, 97.6%, 73.3%, and 97.6%, respectively, for enzyme immunoassay; 93.3%, 97.4%, 75.7%, and 99.4%, respectively, for real-time PCR; 76.7%, 97.1%, 69.7%, and 97.9%, respectively, for cell culture cytotoxin assay; and 100.0%, 95.9%, 68.2%, and 100.0%, respectively, for anaerobic culture (for toxigenic C. difficile strains). The real-time PCR and anaerobic culture assays were significantly more sensitive than the enzyme immunoassay (P < .01 to P < .05). Conclusions. With an assay turnaround time of C. difficile detection in clinical practice, as well as for use during the development of new therapeutic agents.Keywords
This publication has 39 references indexed in Scilit:
- Editorial Commentary:Improving the Treatment ofClostridium difficile–Associated Disease: Where Should We Start?Clinical Infectious Diseases, 2006
- An Update on Diagnosis, Treatment, and Prevention of Clostridium difficile–Associated DiseaseGastroenterology Clinics of North America, 2006
- Rapid diagnosis of toxinogenic Clostridium difficile in faecal samples with internally controlled real-time PCRClinical Microbiology & Infection, 2006
- Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, CanadaClinical Infectious Diseases, 2005
- Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with MetronidazoleClinical Infectious Diseases, 2005
- Clostridium difficileToxins: Mechanism of Action and Role in DiseaseClinical Microbiology Reviews, 2005
- Rapid Detection of Clostridium difficile in Feces by Real-Time PCRJournal of Clinical Microbiology, 2003
- Clostridium difficileCurrent Opinion in Infectious Diseases, 2002
- Role of culture and toxin detection in laboratory testing for diagnosis ofClostridium difficile-associated diarrheaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Clostridium Difficile-Associated Diarrhea and ColitisInfection Control & Hospital Epidemiology, 1995